scholarly journals A Digital Modality Decision Program for Patients With Advanced Chronic Kidney Disease

10.2196/12528 ◽  
2019 ◽  
Vol 3 (1) ◽  
pp. e12528 ◽  
Author(s):  
Ruth Dubin ◽  
Anna Rubinsky
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Advanced Chronic Kidney Disease ◽  
Digital Modality

Phosphate binders in patients with chronic kidney disease: Between the new and the old.

2019 ◽  
pp. 2-3
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Estimated Glomerular Filtration Rate ◽  
Chronic Kidney Disease Stage ◽  
Disease Stage ◽  
Phosphate Binders ◽  
Advanced Chronic Kidney Disease ◽  
Phosphate Retention ◽  
Stage 4 ◽  
Dietary Phosphate

Impaired phosphate excretion by the kidney leads to Hyperphosphatemia. It is an independent predictor of cardiovascular disease and mortality in patients with advanced chronic kidney disease (stage 4 and 5) particularly in case of dialysis. Phosphate retention develops early in chronic kidney disease (CKD) due to the reduction in the filtered phosphate load. Overt hyperphosphatemia develops when the estimated glomerular filtration rate (eGFR) falls below 25 to 40 mL/min/1.73 m2. Hyperphosphatemia is typically managed with oral phosphate binders in conjunction with dietary phosphate restriction. These drugs aim to decrease serum phosphate by binding ingested phosphorus in the gastrointestinal tract and its transformation to non-absorbable complexes [1].

scholarly journals Endocrine contribution to the sexual dysfunction in patients with advanced chronic kidney disease and the role of hyperprolactinemia

Andrologia ◽  
2021 ◽  
Author(s):  
Haitham Elbardisi ◽  
Ahmad Majzoub ◽  
Christiana Daniel ◽  
Fadwa Al.Ali ◽  
Mohamed Elesnawi ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Sexual Dysfunction ◽  
Kidney Disease ◽  
Advanced Chronic Kidney Disease
Sign in / Sign up

Export Citation Format

Share Document